Reduction of NAS in NASH Model<sup>a</sup>.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Reduction of NAS in NASH Modela.
应用场景：
创建时间：
2016-10-27
相关数据集
Rat (Wistar) Liver CDAA Diet 4-8-12 Weeks Ensembl84 (BIBC)
Nonalcoholic steatohepatitis (NASH) is a major cause of liver fibrosis with increasing prevalence worldwide. Currently there are no approved drugs available. The development of new therapies is diffic
NIAID Data Ecosystem40
RNA-Seq analylsis of human NASH and Normal liver tissues
To understand the mechanisms of NASH, we detected mRNA level in human NASH (n=5) and normal tissue (n=5) by RNA-Seq. The normal tissues were collected from the patients who received hepatic haemangio
NIAID Data Ecosystem30
RNA sequencing
CDAHFD mice, CDAHFD induced NASH mice, and CDAHFD induced NASH mice treated with Urolithin C
NIAID Data Ecosystem10
Metagenomic analysis in a mouse model of steatohepatitis
It is previously established that the ratio of Bacteroidetes and Firmicutes, the two dominant phyla that make up over 90% of bacterial phylogenetic types in the human distal gut, is modulated by the d
Mendeley Data2019-07-10 更新30
Identification of Novel Cyclobutane-Based Derivatives as Potent Acetyl-CoA Carboxylase Allosteric Inhibitors for Nonalcoholic Steatohepatitis Drug Discovery
Nonalcoholic steatohepatitis (NASH) has become a leading cause of liver fibrosis and hepatocellular carcinoma; however, there are no efficient drugs for NASH therapy. Acetyl-CoA carboxylase (ACC) is a
NIAID Data Ecosystem30
